BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 23542451)

  • 21. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegaly caused by ectopic growth hormone-releasing hormone production from a bronchial carcinoid tumor.
    Gudbjartsson T; Agnarsson BA; Palsson PS; Johannesson A
    Thorac Cardiovasc Surg; 2011 Apr; 59(3):184-5. PubMed ID: 21480145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I.
    Liu SW; van de Velde CJ; Heslinga JM; Kievit J; Roelfsema F
    Jpn J Clin Oncol; 1996 Feb; 26(1):49-52. PubMed ID: 8551667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
    Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
    Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectopic acromegaly.
    Faglia G; Arosio M; Bazzoni N
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):575-95. PubMed ID: 1521513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Germline p.Gly42Val
    Koehler VF; Jungheim K; Groß U; Iacovazzo D; Mann A; Korbonits M
    Ann Clin Lab Sci; 2017 Sep; 47(5):606-610. PubMed ID: 29066490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous Solid Pseudopapillary Tumor and Insulinoma in an Adolescent MEN1 Patient Presenting with Diagnostic Dilemmas.
    Uçar A; Özgüven B; Battal M; Alparslan Pınarlı F; Özmen E; Yetim A; Yılmaz Y
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):375-379. PubMed ID: 28663159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
    Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
    J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.
    Shintani Y; Yoshimoto K; Horie H; Sano T; Kanesaki Y; Hosoi E; Yokogoshi Y; Bando H; Iwahana H; Kannuki S
    Endocr J; 1995 Jun; 42(3):331-40. PubMed ID: 7670561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
    Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parathyroid glands involvement in multiple endocrine neoplasia].
    Târcoveanu E; Niculescu D; Cotea E; Moldovanu R; Vasilescu A; Crumpei F; Zbranca E; Zugun F; Rusu V; Ferariu D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):482-96. PubMed ID: 21495355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Mulvey CK; Van Loon K; Bergsland EK; Masharani U; Nakakura EK
    Pancreas; 2017 Mar; 46(3):416-426. PubMed ID: 28187108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
    Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
    Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
    Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.